Q4 2023 Holdings
Filed 2024-02-14 | 14 holdings | $123.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Lexeo Therapeutics(LXEO) | Common Stock | 52886X107 | $29.0M | 2,157,623 | 23.5% |
| Replimune Group(REPL) | Common Stock | 76029N106 | $25.3M | 3,001,319 | 20.5% |
| Nuvation Bio(NUVB) | Common Stock Class A | 67080N101 | $22.8M | 15,072,340 | 18.4% |
| enGene Holdings Inc.(ENGN) | Common Stock | 29286M105 | $10.4M | 1,131,175 | 8.5% |
| Morphic Holding | Common Stock | 61775R105 | $8.9M | 309,846 | 7.2% |
| Spruce Biosciences | Common Stock | 85209E109 | $6.3M | 2,161,022 | 5.1% |
| Kronos Bio(KRON1USD) | Common Stock | 50107A104 | $4.8M | 3,818,283 | 3.9% |
| Ikena Oncology | Common Stock | 45175G108 | $4.4M | 2,249,123 | 3.6% |
| Sana Biotechnology, Inc.(SANA) | Common Stock | 799566104 | $3.4M | 843,750 | 2.8% |
| Theseus Pharmaceuticals | Common Stock | 88369M101 | $2.9M | 711,479 | 2.3% |
| Immunic Inc(IMUX) | Common Stock | 4525EP101 | $2.7M | 1,788,160 | 2.2% |
| Syros Pharmaceuticals(SYRS) | Common Stock | 87184Q206 | $2.0M | 251,270 | 1.6% |
| enGene Holdings Inc.(ENGNW) | Warrant | 29286M113 | $403.8K | 475,077 | 0.3% |
| Senti Biosciences, Inc. | Common Stock | 81726A100 | $129.2K | 195,792 | 0.1% |